Salvatora T. Miano
Siena, 53100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Aggressive Angiomyxoma of the Lower Female Genital Tract: A Review of the MITO Rare Tumors Group.
Journal: Cancers
Published: February 12, 2024
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study.
Journal: Translational oncology
Published: October 02, 2020
Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2.
Journal: Medical hypotheses
Published: June 22, 2020
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient.
Journal: Future oncology (London, England)
Published: January 25, 2020
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer.
Journal: Anti-cancer drugs
Published: December 19, 2019
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients.
Journal: Cancer medicine
Published: August 20, 2019
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer.
Journal: Journal of geriatric oncology
Published: April 11, 2019
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer.
Journal: Clinical colorectal cancer
Published: March 21, 2018
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer.
Journal: Future oncology (London, England)
Published: August 29, 2015
Carboplatin, methotrexate, vinblastine, and epirubicin (M-VECa) as salvage treatment in patients with advanced bladder cancer: a phase II study.
Journal: Anti-cancer drugs
Published: June 09, 2015
Last Updated: 09/26/2026